Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-22-033517

VP of Development acquired 14,570 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jiao Jin-an VP of Development 2022-05-31 Option exercise +12,856 $0.14 $1,800 43,427 D: show line 1 in the form
Jiao Jin-an VP of Development 2022-05-31 Option exercise +1,714 $0.21 $360 45,141 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Jiao Jin-an VP of Development 2022-05-31 Option exercise · Stock Option (Right to Buy) −12,856 18,001 D: show line 3 in the form
Jiao Jin-an VP of Development 2022-05-31 Option exercise · Stock Option (Right to Buy) −1,714 6,857 D: show line 4 in the form
Loading xslF345X03/doc4.xml…